
Capture the Major Trends. Control the Downside.
A long-only, rules-based framework for multi-year allocation in core equities and major ETFs, built on 40 years of market experience.
Our long-only approach captures the major trends, protects capital when they break, and repeats the process trend after trend, with drawdowns held to a disciplined fraction of buy and hold. That’s CPR.
Institutional portfolios demand more than static entry and exit signals. acuTRADE is a buy-side-only framework, engineered through decades of market cycles for large-AUM ETFs and equities from $5 billion in market capitalization to the largest companies in the world. It never sells short. Its edge lies in owning the major uptrends and in controlling what happens when they end.
Every position is managed as a lifecycle, not a single call.
When a decline takes hold, acuTRADE exits, and the capital goes back to work. Declines are rarely universal. While one market weakens, others are entering new uptrends. Capital released by an Exit is redeployed into positions carrying active acuTRADE Buy signals or held in short-term Treasuries until the next opportunity appears. In 2022, as the S&P 500 fell 25%, acuTRADE identified positions in Exxon Mobil, ConocoPhillips, Chevron and Vertex Pharmaceuticals as their uptrends took hold against the broader market.
The result is participation with control. On the Dow Jones ETF (DIA), acuTRADE stood aside for nine months during the global financial crisis and for one month during the COVID crash, then bought back in. From 2003 through 2017, buy and hold’s worst drop was 54.4%, while acuTRADE’s deepest drop below a Buy price was 17.6%. From 2018 through 2025, the gap was 38.5% against 4%.
The videos show how acuTRADE handled ten years of history. The tracker shows how it works today, trade by trade, on the funds most investors already own.
It follows 20 of the most widely held index and sector ETFs: 13 standard funds and 7 2X funds. They cover the S&P 500, the Nasdaq 100, the Dow and small caps, along with emerging markets and the major sectors: technology, semiconductors, financials, energy, industrials, health care, utilities and consumer staples. Together they are a cross-section of the whole market.
Every row is a live acuTRADE trade, with the date and price of the Buy, the partial profits taken, and the Gain / Loss from the Buy today. Nothing is selected after the fact, and nothing is left out. The winners and the Exits are both on the table, updated regularly and dated at the top.
This is CPR at work: Capture the trend while it runs, Protect the gains when it breaks, and Repeat when the next trend begins. When a trend turns, the tracker shows it, because that fund moves from Holding to Out.
View acuTRADE Index & ETF Tracker
All charts, videos and results are for educational purposes only and are not investment advice or a recommendation to buy or sell any security.

After a full Exit on February 26, 2025, acuTRADE gave a new Buy on June 16, 2025, at $175.88. Four AT/B (Add To / Buy) signals, at $200.08, $232.57, $328.08 and $366.58, marked chances to add as the uptrend gained strength.
As the trend matured, SP 1 (Scale Partial) sold 20% at $318.98 (+81.4%) and SP 2 (Scale Partial) sold another 20% at $502.79 (+185.9%). AMAT went on to a high of $739.67 on June 30, 2026.
With 40% sold at SP 1 and SP 2 (Scale Partial), 60% of the original position is still held. After the pullback to about $389, that 60% is up 121.4%, and the whole position, counting both SPs (Scale Partial), is up 126.3%.
acuPHASE now reads Distribution 6 (six trading days) with a TRENDweight of -50. Buying strength has faded, an early warning that the trend is weakening.
The label at the right of each chart is a scorecard. It compares the stock traded with acuTRADE against simply buying and holding it.
Top block: the current trade. “OPEN TRADE” shows the Buy price and date, the gain since the Buy, how much is still held, and the highest price since the Buy. “Out” means acuTRADE is not in the stock today. The text turns red when the open trade is below its Buy price.
Three blocks below: the last 1, 3 and 10 calendar years. Each block shows:
From June 2002 to May 2013, acuTRADE navigated three of the sharpest market drawdowns of the last quarter century: the 2002 bear market bottom, the 2008 global financial crisis, and the August 2011 U.S. debt ceiling selloff. For institutional allocators and family offices, downside protection is not about avoiding market exposure – it is about systematic risk governance through full market cycles.
Total Scope: Five sequential campaigns on QQQ (three long, two short) from February 2019 through June 2026.
Methodology: Every price, date, and percentage is derived directly from real charts, capturing the full record, including gains and losses.
Every marker, every date, every price, documented in appendix below. Most trading systems present single, isolated calls in hindsight. acuTRADE is different. Below is an authentic, unedited look at how the acuTRADE algorithmic engine structured and managed capital across five sequential Intel Corporation (INTC) campaigns-navigating entries, executing disciplined scale-outs, flipping short, and capturing macro swings. Every date, price level, and return metric is drawn directly from chart source data.
See where market leadership is emerging and where weakness is developing across U.S., international developed, and emerging markets.
Using the same systematic framework demonstrated in the Dow, Intel, and QQQ analyses, we evaluate 32 major indexes and sector ETFs through both historical campaign performance and current market structure. The result is a top-down view of market strength, sector rotation, and where conditions are changing across equities.
See the current acuTRADE trade in 20 widely held index and sector ETFs: 13 standard funds and 7 2X funds.
Perspectives from respected leaders in investment management, technical analysis, financial research, and academia.
TRENDadvisor’s fully automated position management and systematic risk software is designed to deliver disciplined, multi-year trend exposure for institutional portfolios.